VAERS reports by lot

GSK Varicella/Shingles lot GX25K: VAERS reports

62 VAERS reports list lot GX25K as a GSK Varicella/Shingles vaccine, received between 2019-06-14 and 2020-05-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
62
Reports
3%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction6128%
General / Systemic (non-local)5224%
Dermatological (non-injection-site)3215%
Musculoskeletal2511%
Neurological2411%
Cardiac / Cardiovascular73%
Allergic / Anaphylactic63%
Gastrointestinal63%
Psychiatric / Neuropsychiatric31%
Autoimmune / Immune-mediated21%
Respiratory21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California7
New York5
Pennsylvania4
New Hampshire4
Colorado3
Florida3
Georgia3
New Jersey3
Texas3
Wisconsin2
North Carolina2
New Mexico2

Reports by month received

2019-068
2019-0720
2019-0813
2019-095
2019-105
2019-112
2019-122
2020-012
2020-023
2020-031
2020-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.